CAPLYTA’S Strong Market Adoption Propels Its Rise As A Leading Antipsychotic Therapy | Delveinsight
Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...
Walk to Defeat ALS® Marks 25 Years of Honoring and Supporting People Living with ALS
For 25 years, the Walk to Defeat ALS® has brought together individuals and families impacted by ALS, offering hope, ...
Asia Asset Management5d
Has Bain bailed from tussle for Fuji Soft?
The unusually contentious bidding war between US private equity firms Bain Capital and KKR for Tokyo-listed Fuji Soft looks ...
thearabianpost2d
Bain Capital Nears Acquisition of Mitsubishi’s Pharma Division in $3.2 Billion Deal
Mitsubishi Tanabe Pharma, for over 500 billion yen . This move aligns with Mitsubishi Chemical’s strategy to streamline its operations and concentrate on core sectors such as vehicle electrification, ...
pharmaphorum3d
Four more drugs in keenly watched ALS trial miss the mark
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 ...
Menopause Treatment Market Size in the 7MM was ~USD 10,970 Million in 2023, is expected to grow a significant CAGR by 2034 | DelveInsight
DelveInsight's “Menopause Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding ...
MutualArt.com2d
Takao Tanabe
Heffel Fine Art Auction House hosted its highly-anticipated spring auction, showcasing more than 90 outstanding works of art to a packed sale room, buzzing with excitement. Works by Jean Paul Riopelle ...
pharmaphorum4d
The AI revolution in pharma
The stakes are clear. Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 billion by streamlining the resource- and time ...